Jason S McLellan Selected Research

Jason S McLellan Research Topics

Disease

38	Infections 05/2024 - 01/2012
25	COVID-19 01/2024 - 01/2020
8	Respiratory Tract Infections (Respiratory Tract Infection) 09/2023 - 06/2011
8	Respiratory Syncytial Virus Infections 11/2022 - 02/2010
5	Pneumonia (Pneumonitis) 09/2023 - 08/2014
5	Virus Diseases (Viral Diseases) 01/2022 - 01/2017
4	Bronchiolitis 09/2023 - 04/2015
3	Severe Acute Respiratory Syndrome 11/2021 - 01/2020
2	Crimean Hemorrhagic Fever 03/2024 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2023 - 10/2018
2	Whooping Cough (Pertussis) 01/2022 - 01/2021
2	Coronavirus Infections 11/2021 - 12/2020
2	Fever (Fevers) 01/2021 - 03/2016
2	Paramyxoviridae Infections (Parainfluenza) 11/2016 - 01/2016
2	Gastroenteritis 01/2012 - 07/2011
1	Seizures (Absence Seizure) 02/2024
1	Coma (Comas) 02/2024
1	Encephalitis (Encephalitis, Rasmussen) 02/2024
1	Breakthrough Infections 01/2024
1	COVID-19 breakthrough infections 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Reinfection 11/2022
1	Neoplasms (Cancer) 04/2022
1	Myalgia 01/2022
1	Fatigue 01/2022
1	Headache (Headaches) 01/2022
1	Pain (Aches) 01/2022
1	Vesicular Stomatitis 10/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Congenital Abnormalities (Deformity) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Persistent Infection 01/2017
1	Papillomavirus Infections 01/2017
1	Viremia 03/2016
1	Ebola Hemorrhagic Fever 03/2016
1	Brachydactyly type A1 10/2008
1	Holoprosencephaly (Arhinencephaly) 10/2008
1	Chagas Disease (American Trypanosomiasis) 01/2006
1	Bone Resorption 01/2006

Drug/Important Bio-Agent (IBA)

33	VaccinesIBA 05/2024 - 06/2011
24	Neutralizing AntibodiesIBA 03/2024 - 01/2013
20	AntibodiesIBA 03/2024 - 10/2012
20	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2008
16	Glycoproteins (Glycoprotein)IBA 03/2024 - 01/2013
13	AntigensIBA 02/2024 - 01/2013
11	EpitopesIBA 09/2023 - 01/2017
10	Monoclonal AntibodiesIBA 01/2023 - 02/2010
7	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2012
4	Immunoglobulin G (IgG)IBA 01/2024 - 01/2017
3	2019-nCoV Vaccine mRNA-1273IBA 05/2024 - 06/2020
3	Broadly Neutralizing AntibodiesIBA 05/2024 - 01/2020
3	Respiratory Syncytial Virus VaccinesIBA 11/2022 - 12/2016
3	Polysaccharides (Glycans)IBA 10/2021 - 01/2020
3	Palivizumab FDA Link 01/2017 - 02/2010
2	COVID-19 VaccinesIBA 05/2024 - 06/2020
2	bamlanivimabIBA 12/2021 - 10/2020
2	Angiotensin-Converting Enzyme 2IBA 10/2021 - 01/2020
2	aluminum sulfate (alum)IBA 02/2021 - 01/2021
2	MF59 oil emulsionIBA 01/2020 - 01/2020
1	Viral Fusion ProteinsIBA 03/2024
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 04/2022
1	pertactin FDA Link 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 10/2021
1	IntegrinsIBA 01/2021
1	sisunatovirIBA 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Viral ProteinsIBA 01/2020
1	reluscovtogene ralaplasmidIBA 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	Subunit VaccinesIBA 01/2020
1	NucleosidesIBA 01/2020
1	Alanine (L-Alanine)FDA Link 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	JNJ-53718678IBA 01/2017
1	InterferonsIBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	Capsid Proteins (Capsid Protein)IBA 01/2017
1	ansuvimabIBA 03/2016
1	Edetic Acid (EDTA)FDA Link 02/2012
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 02/2012
1	Protein Isoforms (Isoforms)IBA 02/2012
1	Blood Group Antigens (Blood Groups)IBA 07/2011
1	motavizumab (Numax)IBA 02/2010
1	CalciumIBA 10/2008
1	Diphosphonates (Bisphosphonates)IBA 01/2006

Therapy/Procedure

12	Therapeutics 10/2022 - 01/2006
1	Transcutaneous Electric Nerve Stimulation (TENS) 09/2023
1	Intranasal Administration 01/2021
1	Euthanasia (Mercy Killing) 08/2014